Evidence map›Paper›PMID 38155627›Full record

ArticleNagoya journal of medical science2023

Creation of synthetic contrast-enhanced computed tomography images using deep neural networks to screen for renal cell carcinoma.

Naoto Sassa, Yoshitaka Kameya, Tomoichi Takahashi, Yoshihisa Matsukawa, Tsuyoshi Majima, Katsuhisa Tsuruta, Ikuo Kobayashi, Keishi Kajikawa, Hideji Kawanishi, Haruka Kurosu and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Nagoya journal of medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Naoto SassaDepartment of Urology, Aichi Medical University School of Medicine, Nagakute, Japan.
Yoshitaka KameyaDepartment of Information Engineering, Graduate School of Science and Engineering, Meijo University, Nagoya, Japan.
Tomoichi TakahashiMeis Technology Inc., Nagoya, Japan.
Yoshihisa MatsukawaDepartment of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Tsuyoshi MajimaDepartment of Urology, Aichi Medical University School of Medicine, Nagakute, Japan.
Katsuhisa TsurutaDepartment of Urology, Aichi Medical University School of Medicine, Nagakute, Japan.
Ikuo KobayashiDepartment of Urology, Aichi Medical University School of Medicine, Nagakute, Japan.
Keishi KajikawaDepartment of Urology, Aichi Medical University School of Medicine, Nagakute, Japan.
Hideji KawanishiDepartment of Urology, Aichi Medical University School of Medicine, Nagakute, Japan.
Haruka KurosuDepartment of Urology, Aichi Medical University School of Medicine, Nagakute, Japan.
Sho YamagiwaDepartment of Urology, Aichi Medical University School of Medicine, Nagakute, Japan.
Masaya TakahashiDepartment of Information Engineering, Graduate School of Science and Engineering, Meijo University, Nagoya, Japan.
Kazuhiro HottaDepartment of Information Engineering, Graduate School of Science and Engineering, Meijo University, Nagoya, Japan.
Keiichi YamadaDepartment of Information Engineering, Graduate School of Science and Engineering, Meijo University, Nagoya, Japan.
Tokunori YamamotoNagoya University-NEUROTECH collaborative Regenerative Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we elucidate if synthetic contrast enhanced computed tomography images created from plain computed tomography images using deep neural networks could be used for screening, clinical diagnosis, and postoperative follow-up of small-diameter renal tumors. This retrospective, multicenter study included 155 patients (artificial intelligence training cohort [n = 99], validation cohort [n = 56]) who underwent surgery for small-diameter (≤40 mm) renal tumors, with the pathological diagnosis of renal cell carcinoma, during 2010-2020. We created a learned deep neural networks using pix2pix. We examined the quality of the synthetic enhanced computed tomography images created using this deep neural networks and compared them with real enhanced computed tomography images using the zero-mean normalized cross-correlation parameter. We assessed concordance rates between real and synthetic images and diagnoses according to 10 urologists by creating a receiver operating characteristic curve and calculating the area under the curve. The synthetic computed tomography images were highly concordant with the real computed tomography images, regardless of the existence or morphology of the renal tumor. Regarding the concordance rate, a greater area under the curve was obtained with synthetic computed tomography (area under the curve = 0.892) than with only computed tomography (area under the curve = 0.720; p < 0.001). In conclusions, this study is the first to use deep neural networks to create a high-quality synthetic computed tomography image that was highly concordant with a real computed tomography image. Our synthetic computed tomography images could be used for urological diagnoses and clinical screening.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsArtificial IntelligenceHumansNeural Networks, ComputerRetrospective StudiesTomography, X-Ray Computedartificial intelligencedeep learningdeep neural networkkidney cancerrenal cell carcinoma

Identifiers

PMID38155627
PMCPMC10751485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.